AZN Stock — AstraZeneca PLC

AstraZeneca PLC (AZN)

AZN is a Stock. As of September 3, 2026, its distribution rate is 1.94%, its trailing-12-month yield is 1.96%. Dividend Vision Distribution Safety Score™ is 39/100 (Elevated risk). Total return is 5273.9% over the past 33.3 years, 2227.8 points ahead of SPY at 3046.1%.

At the current 1.94% distribution rate, a $10,000 investment would generate approximately $194 per year, or $16.17 per month on an equivalent basis. Actual semi-annual payments vary.

AstraZeneca PLC is a biopharmaceutical company that discovers, develops, manufactures, and commercializes prescription medicines across oncology, cardiovascular, respiratory, immunology, vaccines, and rare disease therapies, with a global presence spanning the United Kingdom, Americas, Europe, Asia, Africa, and Australasia. The company distributes semi-annually at a modest current distribution rate. It appeals to income-focused equity investors seeking exposure to the pharmaceutical sector.

AZN performance versus SPY

Data as of September 3, 2026.

Total return is 5273.9% over the past 33.3 years, 2227.8 points ahead of SPY at 3046.1%. Its deepest 1-year drawdown was 24.8%.

AZN key facts

Data as of September 3, 2026.

Distribution Safety Score™

39 · Elevated risk

Safety-Adjusted Yield

0.76%

Asset type

Stock

Asset class

Equity

Inception date

05/12/1993

Distribution rate

1.94%

Distribution frequency

Semi-Annual

Trailing yield

1.96%

5-year average yield

2.08

Last close

$164.77

Market cap

$251,445,133,312

Average volume

2425162.0

Next dividend

$1.06

Last ex-dividend date

08/07/2026

Next payment date

09/08/2026

Beta

0.211

Payout ratio

0.6325

P/E ratio

24.74

Forward P/E

16.0514

EPS

$6.66

How Dividend Vision calculates yield and returns

Distribution rate (1.94%) is the latest regular payout annualized by the fund's stated frequency, divided by the last close. Issuers often publish this as “Distribution Rate” on the fact sheet. Trailing-12-month yield (1.96%) is the sum of distributions paid in the last 12 months, split-adjusted, divided by the last close. It lags a recent raise or cut. We show a 30-day SEC yield when the fund publishes one. Schwab and other issuers may report a TTM distribution yield or SEC yield on a different date — all can be valid; they are not interchangeable. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss. Figures below use Dividend Vision data as of September 3, 2026.

Distribution rate methodology · Distribution Safety Score methodology · SEC yield

Sources and review

Data as of September 3, 2026.

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

AZN risks and drawbacks

AZN's current distribution rate is moderate, not a high-yield payout — the strategy is dividend quality more than maximum income. Payments are semi-annual, so cash flow is lumpy versus a monthly fund. The deepest 1-year drawdown on record here is 24.8%.

Who may consider AZN — and who may not

It is a weaker fit for investors who need monthly cash flow (AZN pays semi-annual); investors hunting double-digit covered-call yields. This is educational context, not a recommendation to buy or sell.

Frequently asked questions